Valproate inhibits multiple pharmacological targets. Which of the following mechanisms contributes MOST to its broad-spectrum antiepileptic activity including absence seizures?
- A Block of sustained, repetitive neuronal firing via use-dependent Na+ channel inactivation
- B Inhibition of T-type calcium channels in thalamic relay neurons, interrupting the 3-Hz spike-wave thalamocortical circuit ✓
- C Allosteric potentiation of GABA-A receptor chloride channel opening frequency
- D Inhibition of histone deacetylase (HDAC), upregulating GABAergic gene expression
Explanation
Valproate's mechanism for absence seizure control parallels ethosuximide's: inhibition of T-type (low-threshold) Ca2+ channels in thalamocortical relay neurons disrupts the rhythmic 3-Hz spike-wave oscillations characteristic of absence epilepsy. Additionally, valproate inhibits GABA transaminase (increasing GABA levels) and succinic semialdehyde dehydrogenase, enhancing GABAergic inhibition. Na+ channel blockade and HDAC inhibition are true valproate effects but secondary to the thalamic T-channel mechanism for absence seizures. This multi-target profile explains why valproate alone can treat absence, myoclonic, and generalized tonic-clonic seizures.
Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.